These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13465394)

  • 1. [Effect of N1-sulfanilylo-N2-n-butyl-carbamide in diabetes complicated by tuberculosis].
    LITYNSKI M
    Pol Tyg Lek (Wars); 1957 Jun; 12(23):880-4. PubMed ID: 13465394
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-sulfanilyl-N'-butyl urea (BZ55) therapy of diabetes in patients of pulmonary tuberculosis].
    LENCI E
    Minerva Med; 1958 Apr; 49(31):1482-4. PubMed ID: 13552304
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of death during oral oranil (N1-sulfanilyl-N2-n-butyl carbamide) therapy of diabetes].
    MAIER E
    Z Gesamte Inn Med; 1957 Jun; 12(12):567-70. PubMed ID: 13478054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of sulfonylurea derivatives in diabetes mellitus associated with pulmonary tuberculosis].
    LAURIA D; LIOTTI G; SCOGNAMILLO A
    Riforma Med; 1958 Jun; 72(26):724-7. PubMed ID: 13579942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent experiments in the oral treatment of diabetes with N1-sulfanilyl-N2-butyl urea preparations].
    HORN-MACIEJEWSKA M; BLAWACKA M; ROTH Z
    Pol Tyg Lek (Wars); 1958 Feb; 13(8):282-8. PubMed ID: 13542293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with chloropropamide (diabinese) in average cases of diabetes complicated by active pulmonary tuberculosis].
    GAGALA M; LEWARTOWSKI B
    Pol Tyg Lek; 1960 Dec; 15():1919-22. PubMed ID: 13702911
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methylbutylurea treatment of diabetics with pulmonary tuberculosis].
    FILLA E; FILOGRANA V
    Minerva Med; 1958 Sep; 49(71):3333-6. PubMed ID: 13600137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with sulfonylurea therapy in tuberculosis of diabetic patients].
    MARTON S; BANYASZ T; MEDVECZKY E
    Orv Hetil; 1958 Jun; 99(26):878-84. PubMed ID: 13566802
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities of clinical use of tolbutamide in diabetic tuberculosis patients].
    DADDI G; GRASSI C
    Minerva Med; 1958 Apr; 49(30):1397-9. PubMed ID: 13552267
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of associated diabetes & tuberculosis with peroral antidiabetics].
    REALE M; ANSELMO B; BASSO L; SICCARDI L
    Gazz Med Ital; 1959 Feb; 118(2):51-8. PubMed ID: 13653340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral treatment of diabetes mellitus with sulfanyl-butyl-carbamide].
    FLORES OLLOQUI F
    Rev Esp Enferm Apar Dig Nutr; 1958 Apr; 17(4):400-11. PubMed ID: 13568303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical research on the treatment of diabetic tuberculotics with sulfonylurea].
    VERGANI F; CAMURATI E; CAZZANI E
    G Ital Della Tuberc; 1957; 11(5):311-6. PubMed ID: 13490810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical studies on the use of sulfonyl ureas in tuberculous diabetics].
    GRASSI-GIALDRONI G; VERGANI F; CAMURATI E; CAZZANI E; GRASSI C
    Minerva Med; 1958 Apr; 49(31):1506. PubMed ID: 13552325
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of N1-sulfanilyl-N2-n-butyl carbamide on the progress of alloxan diabetes in rabbits and on the glucagon content in dogs pancreas].
    CZYZK A
    Arzneimittelforschung; 1956 Dec; 6(12):700-1. PubMed ID: 13395925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of N1-sulfanilylo-N2-n-butylcarbamide on course of alloxan diabetes in rabbits and on hyperglycemic factor (glucagon) in pancreatic extracts in dogs].
    CZYZYK A
    Pol Arch Med Wewn; 1957; 27(8):1057-67. PubMed ID: 13505313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oral treatment of diabetes mellitus with N-(4-methylbenzene-sulphonyl)-N-butyl urea (D860).
    MUKHERJEE SK; DE UN; MUKERJI B
    J Indian Med Assoc; 1959 Jun; 32(12):474-8. PubMed ID: 13673164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of the diabetes of patients of pulmonary tuberculosis with chloropropamide].
    ESCALANTE O; POLLITZER J; SILVA NA
    Sem Med; 1961 Jun; 118():1622-5. PubMed ID: 13697306
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of an oral hypoglycaemic agent N-(4-methyl-phenyl sulphanyl)-N1-butylurea in diabetes.
    ISKANDAR N; HABIB SA
    J Egypt Med Assoc; 1958; 41(3-4):225-35. PubMed ID: 13598811
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the total & renal clearance of N1-sulfanilyl-N2-n-butyl-carbamide (nadisan)].
    KLAUS D; STRIPECKE W
    Z Gesamte Inn Med; 1957 Apr; 12(7):289-94. PubMed ID: 13456727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.